Special Session on Prevention of Cardioembolic Stroke, Video 4: Antiplatelet Therapy in Patients Undergoing Structural Heart or Coronary Interventions


Session Summary, Special Session on Prevention of Cardioembolic Stroke, Video 4

When looking at the three scenarios of "correct" antiplatelet therapy post PCI, post LAA closure, and post TAVR, it's clear there is no single answer. Operators are currently in a gray zone until further data come in over the next 18-24 months. It was agreed, however, that triple therapy is to be avoided in all three scenarios if at all possible.

Faculty Disclosure   Vendor Supporters   Program Agenda   IAGS Video Menu